Amicus Therapeutics Inc (FOLD) — Capital Reinvestment Ratio
Amicus Therapeutics Inc (FOLD) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow ($16.25 Million) in capital expenditures ($299.00K). See FOLD equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Amicus Therapeutics Inc Capital Reinvestment Ratio (2007–2025)
This chart tracks Amicus Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. Check Amicus Therapeutics Inc (FOLD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Amicus Therapeutics Inc (2007–2025)
Year-by-year Capital Reinvestment Ratio for Amicus Therapeutics Inc from 2007 to 2025. For live market cap and broader valuation context, see market value of Amicus Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | $33.15 Million | $3.30 Million | ▲ +125.8% |
| 2007 | 0.04x | $15.19 Million | $669.00K | — |